Versant Capital Management Inc lessened its position in UnitedHealth Group Inc (NYSE:UNH) by 12.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 543 shares of the healthcare conglomerate’s stock after selling 78 shares during the period. Versant Capital Management Inc’s holdings in UnitedHealth Group were worth $118,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. First Citizens Bank & Trust Co. lifted its position in UnitedHealth Group by 1.3% during the third quarter. First Citizens Bank & Trust Co. now owns 34,855 shares of the healthcare conglomerate’s stock valued at $7,575,000 after purchasing an additional 463 shares during the period. Cohen Klingenstein LLC lifted its position in UnitedHealth Group by 75.0% during the third quarter. Cohen Klingenstein LLC now owns 24,500 shares of the healthcare conglomerate’s stock valued at $5,324,000 after purchasing an additional 10,500 shares during the period. LexAurum Advisors LLC lifted its position in UnitedHealth Group by 0.7% during the third quarter. LexAurum Advisors LLC now owns 8,494 shares of the healthcare conglomerate’s stock valued at $1,846,000 after purchasing an additional 57 shares during the period. Occidental Asset Management LLC lifted its position in UnitedHealth Group by 270.0% during the third quarter. Occidental Asset Management LLC now owns 4,070 shares of the healthcare conglomerate’s stock valued at $884,000 after purchasing an additional 2,970 shares during the period. Finally, Wedbush Securities Inc. lifted its position in UnitedHealth Group by 2.9% during the third quarter. Wedbush Securities Inc. now owns 23,647 shares of the healthcare conglomerate’s stock valued at $5,139,000 after purchasing an additional 670 shares during the period. Hedge funds and other institutional investors own 85.71% of the company’s stock.
A number of brokerages recently weighed in on UNH. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $298.00 to $294.00 and set an “overweight” rating on the stock in a research report on Thursday, September 26th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price objective on the stock in a research report on Monday, July 22nd. Raymond James increased their price objective on shares of UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a research report on Friday, July 19th. Barclays set a $260.00 target price on shares of UnitedHealth Group and gave the company a “buy” rating in a report on Tuesday, October 8th. Finally, Royal Bank of Canada set a $311.00 target price on shares of UnitedHealth Group and gave the company a “buy” rating in a report on Friday, July 19th. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $283.84.
Shares of NYSE UNH traded up $1.67 during midday trading on Friday, reaching $245.34. The stock had a trading volume of 4,853,838 shares, compared to its average volume of 5,620,834. The stock has a 50-day moving average of $227.43 and a 200-day moving average of $239.63. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.67 and a current ratio of 0.70. The company has a market capitalization of $230.92 billion, a price-to-earnings ratio of 19.05, a price-to-earnings-growth ratio of 1.29 and a beta of 0.60. UnitedHealth Group Inc has a 12-month low of $208.07 and a 12-month high of $287.94.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.75 by $0.13. The firm had revenue of $60.35 billion during the quarter, compared to analysts’ expectations of $59.84 billion. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The company’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period in the prior year, the company posted $3.41 earnings per share. As a group, analysts forecast that UnitedHealth Group Inc will post 14.96 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a $1.08 dividend. The ex-dividend date of this dividend was Friday, September 13th. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.76%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.54%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: Day Trading
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.